Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
1.630
+0.010 (0.62%)
Nov 21, 2024, 4:00 PM EST - Market closed

Biora Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Market Capitalization
63729374296-
Upgrade
Market Cap Growth
-63.86%24.98%-92.14%26.17%--
Upgrade
Enterprise Value
41108123477310-
Upgrade
Last Close Price
1.6213.5032.92522.501327.50-
Upgrade
PS Ratio
5.489183.1396.37299.751828.75-
Upgrade
PB Ratio
-0.17-0.36-0.29-4.40-2.77-
Upgrade
EV/Sales Ratio
46.3626878.38404.76382.911910.59-
Upgrade
Debt / Equity Ratio
-0.36-0.47-1.27-1.49-1.52-0.87
Upgrade
Asset Turnover
0.040.000.000.010.001.32
Upgrade
Inventory Turnover
-----10.83
Upgrade
Quick Ratio
0.030.251.341.451.360.56
Upgrade
Current Ratio
0.050.301.641.601.740.74
Upgrade
Return on Assets (ROA)
-154.63%-99.04%-47.56%-55.95%-52.51%-80.30%
Upgrade
Return on Capital (ROIC)
---111.31%-151.02%-298.17%-693.16%
Upgrade
Earnings Yield
-522.91%-337.89%-129.82%-66.19%-64.99%-
Upgrade
FCF Yield
-766.03%-132.31%-221.86%-45.04%-57.25%-
Upgrade
Buyback Yield / Dilution
-159.11%-106.59%-98.51%-249.49%-463.47%-4.84%
Upgrade
Total Shareholder Return
-159.11%-106.59%-98.51%-249.49%-463.47%-4.84%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.